Oxford Handbook of Clinical Haematology
5th Edition
Will be published approx. on 26. January 2027
Book
Part-work (fascículo)
944 pages
978-0-19-884399-3 (ISBN)
Description
The Oxford Handbook of Clinical Haematology provides core and concise information on the entire spectrum of blood disorders affecting both adults and children. Fully updated for its fifth edition, it includes all major advances in the specialty, including malignant haematology, haemato-oncology, coagulation, transfusion medicine, and red cell disorders. Practically focused, and specifically designed for ease-of-use, and rapid access to the information you need, this handbook is an indispensable resource on all aspects of haematology for all trainee doctors, nurses, technicians, and research professionals.
The handbook is divided into clinical approach and disease-specific areas. The clinical approach section outlines various symptoms and signs in patients with blood disease to enable the reader to formulate a sensible differential diagnosis before embarking on investigation and treatment. The disease-specific section is written by authors whose expertise covers the whole breadth of diseases included in the book. All authors have contributed to national guidelines (e.g. British Committee for Standards in Haematology, BCSH) and are experts in the evidence base that exists for each topic.
The Oxford Handbook of Clinical Haematology offers a concise and logical approach to caring for patients with diseases of the blood.
The handbook is divided into clinical approach and disease-specific areas. The clinical approach section outlines various symptoms and signs in patients with blood disease to enable the reader to formulate a sensible differential diagnosis before embarking on investigation and treatment. The disease-specific section is written by authors whose expertise covers the whole breadth of diseases included in the book. All authors have contributed to national guidelines (e.g. British Committee for Standards in Haematology, BCSH) and are experts in the evidence base that exists for each topic.
The Oxford Handbook of Clinical Haematology offers a concise and logical approach to caring for patients with diseases of the blood.
More details
Series
Edition
5th Revised edition
Language
English
Place of publication
Oxford
United Kingdom
Target group
Professional and scholarly
Edition type
Revised edition
Illustrations
51 figures
Dimensions
Height: 180 mm
Width: 100 mm
ISBN-13
978-0-19-884399-3 (9780198843993)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Drew Provan is Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. Dr. Provan studied molecular genetics at Leicester University before studying medicine. Dr. Provan took up the post of Consultant Haematologist in Southampton in 1995, and moved to Barts and The London in 2000. As a general haematologist, his main area of interest within the field of haematology is immunohaematology which includes diseases such as autoimmune thrombocytopenia (ITP), neutropenia and haemolytic anaemia. Dr. Provan has established the UK ITP Registry (www.ukitpregistry.com ) and has recently published the Consensus guidelines for the diagnosis and management of ITP in children and adults published in Blood. He has written numerous peer-reviewed papers, book chapters, and has authored several medical books including Oxford Handbook of Clinical and Laboratory Investigation.
Will Lester is a Consultant Haematologist at University Hospitals Birmingham, Clinical Service Lead for Haematology at Birmingham Women's Hospital, and an Honorary Clinical Associate Professor in the Institute of Cardiovascular Sciences, University of Birmingham, UK. He is Clinical Director of UK NEQAS blood coagulation and Chair of the British Society of Haematology Haemostasis and Thrombosis guidelines taskforce. His clinical and academic interests include immuno-haematology, haemostasis and thrombosis and obstetric haematology.
Inderjeet Dokal graduated in Medicine from the University of Leicester in 1983. He moved to Hammersmith Hospital in 1984 where he received his post graduate clinical and research training. He was appointed Consultant in Paediatric Haematology in 1995 and was conferred the title of Professor of Haematology at Imperial College in 2003. In 2006 he was recruited to the Chair of Child Health at Barts and The London/Queen Mary University of London. Inderjeet Dokal's principal clinical and research interest is the in the field of bone marrow failure.
Johannes de Vos is Consultant Haematologist, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. After graduation summa cum laude from the Catholic University of Leuven, Belgium, Dr de Vos has worked in Belgium and the Netherlands before moving to the United Kingdom in 2004. After completing his higher medical training in Haematology and becoming a Fellow of the Royal College of Pathologists he worked as a Haemato-Oncology consultant at St Bartholomew's Hospital in London, United Kingdom, before moving to the Royal Surrey County Hospital in Guildford, UK. With a broad interest in all aspects of haematology he is truly 'malignant at heart'. A true clinician Dr de Vos spends almost all his time at the bedside talking to and treating his patients. As a keen teacher he is keen to inspire and pass on in all his resident doctors and students a small part of what inspired him as a student about the incredible world of haematology.
Will Lester is a Consultant Haematologist at University Hospitals Birmingham, Clinical Service Lead for Haematology at Birmingham Women's Hospital, and an Honorary Clinical Associate Professor in the Institute of Cardiovascular Sciences, University of Birmingham, UK. He is Clinical Director of UK NEQAS blood coagulation and Chair of the British Society of Haematology Haemostasis and Thrombosis guidelines taskforce. His clinical and academic interests include immuno-haematology, haemostasis and thrombosis and obstetric haematology.
Inderjeet Dokal graduated in Medicine from the University of Leicester in 1983. He moved to Hammersmith Hospital in 1984 where he received his post graduate clinical and research training. He was appointed Consultant in Paediatric Haematology in 1995 and was conferred the title of Professor of Haematology at Imperial College in 2003. In 2006 he was recruited to the Chair of Child Health at Barts and The London/Queen Mary University of London. Inderjeet Dokal's principal clinical and research interest is the in the field of bone marrow failure.
Johannes de Vos is Consultant Haematologist, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. After graduation summa cum laude from the Catholic University of Leuven, Belgium, Dr de Vos has worked in Belgium and the Netherlands before moving to the United Kingdom in 2004. After completing his higher medical training in Haematology and becoming a Fellow of the Royal College of Pathologists he worked as a Haemato-Oncology consultant at St Bartholomew's Hospital in London, United Kingdom, before moving to the Royal Surrey County Hospital in Guildford, UK. With a broad interest in all aspects of haematology he is truly 'malignant at heart'. A true clinician Dr de Vos spends almost all his time at the bedside talking to and treating his patients. As a keen teacher he is keen to inspire and pass on in all his resident doctors and students a small part of what inspired him as a student about the incredible world of haematology.
Author
Emeritus Reader in HaematologyEmeritus Reader in Haematology, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, UK
Consultant HaematologistConsultant Haematologist, University Hospitals Birmingham NHS Foundation Trust, UK
Emeritus Professor and Honorary Consultant in HaematologyEmeritus Professor and Honorary Consultant in Haematology, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Consultant Haemato-OncologistConsultant Haemato-Oncologist, Barts Health NHS Trust, London, UK
Content
1: Clinical approach 2: Red cell disorders 3: White blood cell abnormalities 4: Leukaemia 5: Lymphoma 6: Myelodysplasia 7: Myeloproliferative neoplasms 8: Plasma cell dyscrasias 9: Haematopoietic stem cell transplantation (HSCT) 10: Haemostasis and thrombosis 11: Immunodeficiency 12: Paediatric haematology 13: Haematological emergencies 14: Supportive care 15: Protocols and guidelines 16: Haematological investigations 17: Blood transfusion 18: Rare diseases Appendix 1: Charts and nomograms Appendix 2: Normal ranges